‫”سيام – شركة المنتجات الخرسانية والركام” و”سامسونج إي آند ايه” توقعان مذكرة تفاهم

لتعزيز تكنولوجيا الطباعة ثلاثية الأبعاد والمواد الأسمنتية الخاصة في السوق العالمية
بانكوك، تايلاند – 2 سبتمبر 2024 – بالنيابة عن شركة المنتجات الخرسانية والركام (CPAC)، وهي شركة أسمنت ومواد بناء تابعة لمجموعة سيام للأسمنت (SCG)، وقع السيد/ ثاماساك سيثودوم، رئيس مجلس الإدارة والرئيس التنفيذي لشركة سيام (الثاني من اليسار) والسيد/ سوراتشاي نيملاور، رئيس شركة سيام للأسمنت والحلول الخضراء (الأول من اليسار)، مذكرة تفاهم مع السيد/ هونغ نامكونغ، رئيس مجلس الإدارة والرئيس التنفيذي لشركة سامسونج إي آند ايه المحدودة (الثاني من اليمين) والسيد/ دونغ هيون كيم، نائب الرئيس التنفيذي لقسم تكنولوجيا الهندسة لشركة سامسونج إي آند ايه المحدودة (الأول من اليمين) للتعاون في مجال الطباعة ثلاثية الأبعاد وفرص تسويق المواد الأسمنتية الخاصة، والتي تجمع بين الخبرة الدولية لشركة سامسونج إي آند ايه ومقرها كوريا الجنوبية في حلول البناء الشاملة وسجل التميز لشركة المنتجات الخرسانية والركام الذي يمتد لأكثر من 100 عام في منتجات الأسمنت والخرسانة والتكنولوجيا معًا لرفع مستوى صناعة البناء التايلاندية لتتناسب مع المستوى العالمي، بالطابق الحادي والعشرين، بالمقر الرئيسي لشركة سيام، في بانكوك، تايلاند، في 21 أغسطس 2024.

وتظهر مذكرة التفاهم هذه أن الشركتين تشتركان في نفس الرؤية في قيادة مستقبل البناء المستدام في العالم من خلال الابتكار والتكنولوجيا الجديدة، وخاصة تقنية الطباعة ثلاثية الأبعاد التي توفر كفاءة أعلى في الإنتاج وتقلل الأخطاء من خلال تمكين عملية الأتمتة من ملف رقمي تم إنشاؤه بواسطة برنامج كمبيوتر. يمكن أن يساعد هذا أيضًا في حل مشكلة نقص القوى العاملة الماهرة، وتقصير فترة البناء، وتقليل نفايات البناء وتكاليف البناء مقارنة بالبناء التقليدي. وتتضمن مذكرة التفاهم أيضًا التعاون البحثي في ​​علوم المواد والآلات والمعدات بالإضافة إلى تبادل المعرفة حول البناء بالطباعة ثلاثية الأبعاد والمواد الأسمنتية الخاصة. تخطط شركة سامسونج إي آند ايه لاستخدام 350 طنًا من ​​مونة الطباعة ثلاثية الأبعاد الحاصل على براءة اختراع، والذي يمكنه تطوير هياكل معقدة التصميم ذات قوة عالية للغاية، لبناء مبنى في المملكة العربية السعودية. بالنسبة لهذا المشروع، ستقدم شركة المنتجات الخرسانية والركام الدعم الاستشاري التكنولوجي حول الطباعة ثلاثية الأبعاد، والاستشارات الهندسية، ودعم تقييم المشروع للخدمات المهنية في التصميم المعماري وغيرها من الاعتبارات الجمالية بالإضافه إلى المونة اللازمه للطباعة ثلاثية الأبعاد.

من اليسار إلى اليمين

  1. السيد/ سوراتشاي نيملاور رئيس شركة سيام للأسمنت والحلول الخضراء
  2. السيد/ ثاماساك سيثودوم الرئيس والرئيس التنفيذي لمجموعة سيام للأسمنت
  3. السيد/ هونغ نامكونغ الرئيس والرئيس التنفيذي لشركة سامسونج إي آند ايه المحدودة
  4. السيد/ دونج هيون كيم نائب الرئيس التنفيذي لقسم تكنولوجيا الهندسة بشركة سامسونج إي آند ايه المحدودة

 

‫فينفاست في الشرق الأوسط: بداية قوية لنجاح محقق

تسعى شركة فينفاست إلى تحقيق الريادة في سوق المركبات الكهربائية الناشئة في الشرق الأوسط للترويج مبكرًا لعلامتها التجارية ولضمان ولاء العملاء، وذلك تمهيدًا للنجاح على المدى الطويل في المنطقة.

 

هانوي، فيتنام – 2 سبتمبر 2024 – بدأ سباق الهيمنة على سوق المركبات الكهربائية، وشركة فينفاست التابعة لمجموعة فينجروب، التي تُعد أكبر تكتل تجاري خاص في فيتنام، تنطلق سريعًا نحو مقدمة السباق.

مجمع فينفاست لتصنيع المركبات الكهربائية في هاي فونج، فيتنام

أعلن مؤسس الشركة، فام نات فونج، ذات مرة، “أن لا مفر من تزايد الإقبال على المركبات الكهربائية”، مؤكدًا اقتناع فينفاست الراسخ بتطور التنقل بالمركبات الكهربائية مستقبلًا، وكان هذا الاقتناع هو الدعامة الأساسية لاستراتيجية الشركة، ما دفعها إلى خوض سباق عالمي يتطلب ترسيخ أعمالها في الأسواق الناشئة.

في سوق المركبات الكهربائية حديثة العهد، تقدمت شركة فينفاست الناشئة بخطى سريعة إلى أسواق متعددة، فأثارت إعجاب مجلة TIME التي أدرجتها في قائمة أكثر 100 شركة تأثيرًا في العالم لعام 2024. رسخت فينفاست  أعمالها في عدة مناطق بمختلف أنحاء العالم، بما في ذلك آسيا وأمريكا الشمالية وأوروبا والشرق الأوسط.

إن اختيار شركة فينفاست لمنطقة الشرق الأوسط لتكون ضمن أسواقها الرئيسية أمر مثير للاهتمام نظرًا لاعتماد هذه المنطقة منذ القِدم على الوقود الأحفوري وارتباطها بانعدام الوعي البيئي. مع ذلك، فإن هذا الاختيار يدل على النهج الأساسي لشركة فينفاست وهو الانطلاق سريعًا إلى بداية السباق لتأمين ريادتها في سوق ناشئة والترويج بقوة لعلامتها التجارية، ثم مواصلة مسار السباق الطويل حتى تصل إلى خط النهاية.

تعد هذه الاستراتيجية مناسبة بالذات للأسواق الناشئة مثل الشرق الأوسط حيث يندُر المنافسون الراسخون ويتزايد الطلب على المركبات الكهربائية. تمثل منطقة الشرق الأوسط، بسكانها الأثرياء وتزايد اهتمامها بالتقنيات المستدامة، أرضًا خصبة لتوسع فينفاست. على سبيل المثال، من المتوقع أن ينمو سوق المركبات الكهربائية في المنطقة بمعدل نمو سنوي مركب بنسبة 28.9٪ بحلول عام 2028، وذلك طبقًا لما ورد عن مؤسسة 6Wresearch. تهدف دولة الإمارات العربية المتحدة وحدها إلى أن تكون 30٪ من مركباتها كهربائية بحلول عام 2030، وقد حددت المملكة العربية السعودية هدفًا طموحًا لاعتماد 30٪ من المركبات الكهربائية في الرياض بحلول عام 2030.

تلبي منتجات فينفاست المتنوعة من سيارات الدفع الرباعي الكهربائية والدراجات البخارية الكهربائية والحافلات الكهربائية احتياجات وتفضيلات المستهلكين المختلفة في المنطقة. علاوة على ذلك، فإن تركيز الشركة على التكنولوجيا الذكية، إلى جانب الالتزام بالتسعير الشامل، يجعلها خيارًا جذابًا للمستهلكين في الشرق الأوسط الذين يبحثون بشكل متزايد عن بدائل للسيارات التقليدية التي تعمل بالبنزين.

يبدو أن نهج فينفاست يكتسب بمرور الوقت مزيدًا من المصداقية مع تزايد المنافسة في الشرق الأوسط؛ فالعلامات التجارية العالمية تعمل على زيادة منتجاتها من المركبات الكهربائية في المنطقة، ونشأت علامات تجارية محلية متخصصة في تصنيع المركبات الكهربائية كما أن الدعم الحكومي لإنتاجها يتزايد في دول مثل الإمارات العربية المتحدة والمملكة العربية السعودية. كل هذه التطورات تجعل سوق الشرق الأوسط أكثر جاذبية للشركات المحلية والدولية.

تقدمت شركة فينفاست بسرعة وتفوقت فاحتلت الصدارة في سوق الشرق الأوسط. كما أن مبادرة الشركة بتأسيس أعمالها في هذه السوق يسمح لها بترسيخ وجودها قبل تزاحم المنافسة، ما يتيح لها وقت كاف للترويج لعلامتها التجارية وكسب ثقة العملاء.

الطريق طويل لكن سباق فينفاست الاستراتيجي بدأ وهي تتقدم بعزم. مع تطور سوق المركبات الكهربائية في الشرق الأوسط، صارت الشركة مهيئة لجني ثمار استثماراتها المبكرة وتعزيز وجودها وترسيخ علامتها التجارية. لا تتعلق صناعة المركبات الكهربائية بالسرعة فحسب، بل تتعلق أيضًا بالتحمل، وفينفاست تستعد لكليهما.

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERV

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 28, 2024 in the securities class action first filed by the Firm.

SO WHAT: If you purchased Verve Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Verve Therapeutics class action, go to https://rosenlegal.com/submit-form/?case_id=28262 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 28, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose, among other things, that: (1) defendants did not fully disclose the circumstances under which the Heart-1 Phase 1b clinical trial (the “Heart-1 Trial”) of VERVE-101 would be halted (VERVE-101 is an investigational gene editing medicine designed to be a single course treatment that permanently turns off the PCSK9 gene in the liver to reduce disease-driving low-density lipoprotein cholesterol (LDL-C)); (2) defendants overstated the potential benefits of its proprietary lipid nanoparticle (LNP) delivery system; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Verve Therapeutics class action, go to https://rosenlegal.com/submit-form/?case_id=28262 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com


GlobeNewswire Distribution ID 9223659

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages STMicroelectronics N.V. to Secure Counsel Before Important Deadline in Securities Class Action – STM

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action on behalf of purchasers of securities of STMicroelectronics N.V. (NYSE: STM) between January 25, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 22, 2024.

SO WHAT: If you purchased STMicroelectronics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the STMicroelectronics class action, go to https://rosenlegal.com/submit-form/?case_id=28219 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 22, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to prior representations, demand in ST’s automotive and industrial sectors continued to decline in the first half of 2024; (2) as a result, ST’s revenues and gross margins also continued to decline during this period; and (3) as a result, ST’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the STMicroelectronics class action, go to https://rosenlegal.com/submit-form/?case_id=28219 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 9223655

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Stellantis N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STLA

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Stellantis N.V. (NYSE: STLA) between February 15, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 15, 2024.

SO WHAT: If you purchased Stellantis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Stellantis class action, go to https://rosenlegal.com/submit-form/?case_id=27632 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 15, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants provided investors with material information regarding Stellantis’ expected revenue for 2024. Defendants’ statements included, among other things, Stellantis’ reduction of inventory levels, pricing improvements, and expansion of its product offering thereby supporting defendants’ decision to forecast double-digit adjusted operating income (“AOI”) margin in 2024, as well as positive industrial free cash flow. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning inventory levels, pricing and market share stabilizations. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Stellantis class action, go to https://rosenlegal.com/submit-form/?case_id=27632 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 9223653

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Sprinklr, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CXM

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) —

WHY: New York, N.Y., September 1, 2024. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sprinklr, Inc. (NYSE: CXM) between March 29, 2023 and June 5, 2024, both dates inclusive (the “Class Period”), of the important October 15, 2024 lead plaintiff deadline.

SO WHAT: If you purchased Sprinklr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Sprinklr class action, go to https://rosenlegal.com/submit-form/?case_id=27960 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 15, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, statements made throughout the Class Period were false and/or materially misleading because defendants created the false impression that they possessed reliable information pertaining to Sprinklr’s projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations. In truth, Sprinklr had significantly shifted its focus away from proven growth areas to focus aggressively on scaling a new business venture with Contact Center as a Service (“CCaaS”), resulting in artificially inflated short-term growth. Defendants misled investors by continually providing projections which failed to account for the difficulties in the implementation of scaling their new product and/or otherwise failed to adequately disclose the fact that Sprinklr at the current time did not have adequate forecasting processes. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Sprinklr class action, go to https://rosenlegal.com/submit-form/?case_id=27960 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com


GlobeNewswire Distribution ID 9223651

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Sprinklr, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CXM

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) —

WHY: New York, N.Y., September 1, 2024. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sprinklr, Inc. (NYSE: CXM) between March 29, 2023 and June 5, 2024, both dates inclusive (the “Class Period”), of the important October 15, 2024 lead plaintiff deadline.

SO WHAT: If you purchased Sprinklr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Sprinklr class action, go to https://rosenlegal.com/submit-form/?case_id=27960 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 15, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, statements made throughout the Class Period were false and/or materially misleading because defendants created the false impression that they possessed reliable information pertaining to Sprinklr’s projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations. In truth, Sprinklr had significantly shifted its focus away from proven growth areas to focus aggressively on scaling a new business venture with Contact Center as a Service (“CCaaS”), resulting in artificially inflated short-term growth. Defendants misled investors by continually providing projections which failed to account for the difficulties in the implementation of scaling their new product and/or otherwise failed to adequately disclose the fact that Sprinklr at the current time did not have adequate forecasting processes. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Sprinklr class action, go to https://rosenlegal.com/submit-form/?case_id=27960 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com


GlobeNewswire Distribution ID 9223651

PM highlights efforts to secure drugs


Prime Minister Moustafa Madbouli said that the government has exerted strenuous effort throughout the past period to ensure the availability of medicines through facilitation of custom release of the imported drugs and raw materials required for their manufacturing.

He added that the release of drugs from ports has contributed to fulfilling the market demand of drugs.

The premier made the remarks during a meeting with Egyptian Drug Authority Chairman Ali Ghamrawy – at the government headquarters in New Alamein City Sunday night – to get posted on availability of drugs in the Egyptian market.

The pharmaceutical industry is of top priority for the government, Madbouli said.

The drug authority exerts utmost efforts to secure medicine, Ghamrawy said, adding that the authority succeeded in boosting the amount of drugs in the market and will be working on securing the remaining types of drugs within few weeks.

The head of the drug authority reviewed cooperation with the World Health Organization (WHO) as well
as efforts aimed at supporting the pharmaceutical industry, in line with the international standards.

Source: State Information Service Egypt

PM highlights efforts to secure drugs


Prime Minister Moustafa Madbouli said that the government has exerted strenuous effort throughout the past period to ensure the availability of medicines through facilitation of custom release of the imported drugs and raw materials required for their manufacturing.

He added that the release of drugs from ports has contributed to fulfilling the market demand of drugs.

The premier made the remarks during a meeting with Egyptian Drug Authority Chairman Ali Ghamrawy – at the government headquarters in New Alamein City Sunday night – to get posted on availability of drugs in the Egyptian market.

The pharmaceutical industry is of top priority for the government, Madbouli said.

The drug authority exerts utmost efforts to secure medicine, Ghamrawy said, adding that the authority succeeded in boosting the amount of drugs in the market and will be working on securing the remaining types of drugs within few weeks.

The head of the drug authority reviewed cooperation with the World Health Organization (WHO) as well
as efforts aimed at supporting the pharmaceutical industry, in line with the international standards.

Source: State Information Service Egypt

PM highlights efforts to secure drugs


Prime Minister Moustafa Madbouli said that the government has exerted strenuous effort throughout the past period to ensure the availability of medicines through facilitation of custom release of the imported drugs and raw materials required for their manufacturing.

He added that the release of drugs from ports has contributed to fulfilling the market demand of drugs.

The premier made the remarks during a meeting with Egyptian Drug Authority Chairman Ali Ghamrawy – at the government headquarters in New Alamein City Sunday night – to get posted on availability of drugs in the Egyptian market.

The pharmaceutical industry is of top priority for the government, Madbouli said.

The drug authority exerts utmost efforts to secure medicine, Ghamrawy said, adding that the authority succeeded in boosting the amount of drugs in the market and will be working on securing the remaining types of drugs within few weeks.

The head of the drug authority reviewed cooperation with the World Health Organization (WHO) as well
as efforts aimed at supporting the pharmaceutical industry, in line with the international standards.

Source: State Information Service Egypt